Lenox Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1K Sell
2
-4
-67% -$1K ﹤0.01% 710
2021
Q4
$2K Buy
+6
New +$1.47K ﹤0.01% 721
2020
Q1
Sell
-2
Closed 845
2019
Q4
$0 Buy
+2
New +$269 ﹤0.01% 763
2016
Q1
Sell
-93
Closed -$6K 320
2015
Q4
$6K Buy
+93
New +$6.49K ﹤0.01% 210
2014
Q1
Sell
-47
Closed -$2K 254
2013
Q4
$2K Buy
+47
New +$2.17K ﹤0.01% 304
2013
Q3
Sell
-190
Closed -$7K 269
2013
Q2
$7K Buy
+190
New +$7.35K 0.01% 144

Other funds holding HCA

Lenox Wealth Advisors's HCA Position: Q1 2022 in Review

Lenox Wealth Advisors reduced its HCA Healthcare (HCA) stake by 67% in Q1 2022, selling an estimated $1K and leaving 2 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #710.

Lenox Wealth Advisors first reported a position in HCA in Q2 2013 and has held it in 6 quarters since. The position peaked at $7K in Q2 2013. 969 funds tracked by Wall St. Rank hold HCA as of Q1 2022.

  • Lenox Wealth Advisors held 2 shares of HCA Healthcare worth $1K as of Q1 2022.
  • Lenox Wealth Advisors sold 4 HCA Healthcare shares in Q1 2022, an estimated $1K.
  • HCA Healthcare made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #710 holding.
  • Lenox Wealth Advisors first reported a position in HCA Healthcare in Q2 2013 and has held it in 6 quarters since.
  • Lenox Wealth Advisors's HCA Healthcare position peaked at $7K in Q2 2013.
  • 969 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.